PT606452E - Vacinas de vector de virus de herpes felino recombinante - Google Patents

Vacinas de vector de virus de herpes felino recombinante

Info

Publication number
PT606452E
PT606452E PT93917639T PT93917639T PT606452E PT 606452 E PT606452 E PT 606452E PT 93917639 T PT93917639 T PT 93917639T PT 93917639 T PT93917639 T PT 93917639T PT 606452 E PT606452 E PT 606452E
Authority
PT
Portugal
Prior art keywords
fhv
recombinant feline
vector vectors
feline herpes
mutant
Prior art date
Application number
PT93917639T
Other languages
English (en)
Inventor
Paulus Jacobus An Sondermeijer
Martha Jacoba Willemse
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210815&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT606452(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT606452E publication Critical patent/PT606452E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
PT93917639T 1992-07-30 1993-07-23 Vacinas de vector de virus de herpes felino recombinante PT606452E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92202365 1992-07-30

Publications (1)

Publication Number Publication Date
PT606452E true PT606452E (pt) 2003-03-31

Family

ID=8210815

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93917639T PT606452E (pt) 1992-07-30 1993-07-23 Vacinas de vector de virus de herpes felino recombinante

Country Status (10)

Country Link
US (1) US6521236B1 (pt)
EP (1) EP0606452B1 (pt)
JP (1) JP3529134B2 (pt)
AT (1) ATE227775T1 (pt)
AU (1) AU4702293A (pt)
DE (1) DE69332480T2 (pt)
DK (1) DK0606452T3 (pt)
ES (1) ES2187508T3 (pt)
PT (1) PT606452E (pt)
WO (1) WO1994003621A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000172A1 (en) * 1993-06-24 1995-01-05 Michigan State University Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof
AU2234995A (en) * 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
HUP0200320A3 (en) * 1998-05-01 2006-03-28 Schering Plough Ltd Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
JP2002112770A (ja) 2000-10-05 2002-04-16 Kyoritsu Seiyaku Kk 新規組換えネコヘルペスウイルス1型およびこれを用いた多価ワクチン
WO2009051823A2 (en) * 2007-10-18 2009-04-23 Michigan State University Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591145B2 (en) * 1985-07-29 1989-11-30 Pharmacia & Upjohn Company Virus vaccine with deletion of an antigen of the wild-type virus
US5223424A (en) * 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
EP0256092B1 (en) * 1986-01-27 1998-04-08 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
US5324664A (en) * 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
WO1995000172A1 (en) 1993-06-24 1995-01-05 Michigan State University Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof

Also Published As

Publication number Publication date
JPH06511392A (ja) 1994-12-22
DE69332480T2 (de) 2003-07-17
AU4702293A (en) 1994-03-03
WO1994003621A1 (en) 1994-02-17
ATE227775T1 (de) 2002-11-15
US6521236B1 (en) 2003-02-18
DE69332480D1 (de) 2002-12-19
DK0606452T3 (da) 2003-03-17
EP0606452B1 (en) 2002-11-13
ES2187508T3 (es) 2003-06-16
JP3529134B2 (ja) 2004-05-24
EP0606452A1 (en) 1994-07-20

Similar Documents

Publication Publication Date Title
CA2031164A1 (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
CA2161962A1 (en) Adenovirus vectors for gene therapy
MX9700833A (es) Virus de herpes recombinante de pavo y usos del mismo.
GB2263480B (en) Viral defective vaccine produced by transcomplementing cell line
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
EP0596979A4 (en) Recombinant plant viral nucleic acids.
EP0677114A4 (en) RECOMBINED PIGROCK VIRUS.
PT576092E (pt) Vacina de virus de herpes felino recombinante
ATE227775T1 (de) Impfstoff-vektoren von rekombinantem katzen- herpesvirus
NO922728L (no) Vaksine mot coccidiose
NZ508892A (en) Nucleic acid encoding a vaccine-induced mutant major surface antigen of a hepatitis B viral strain
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
EP0513921A3 (en) Recombinant vaccine against marek's disease
CA2196416A1 (en) Recombinant herpes virus with gb gene promoter
CY2540B1 (en) Vaccine against mumps containing a jeryl-lynn virus strain
Willemse et al. Recombinant feline herpesvirus vaccine
MY118955A (en) Mutant human hepatitis b viral strain and uses thereof.
Keil Vector vaccines of bovine herpesvirus I
MX9709514A (es) Viruses de fowlpox recombinantes y usos de los mismos.
TH11952A (th) ไวรัสของโรคมาเรคที่ตัดต่อสารพันธุกรรมขึ้นใหม่และ?วัคซีน